Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Lung Cancer treatment details. Chemotherapy. Louisiana Oncology Associates, Lafayette, Louisiana, United States

Survival: 7.0 months
Toxicity Grade: 4
Treatments: Chemotherapy
Drugs: Gemzar
Country: United States
City/State/Province: Lafayette, Louisiana
Hospital: Louisiana Oncology Associates
Journal: Link
Date: 9/2002

Patients: This Phase II study involved 35 patients with unresectable (i.e. inoperable) advanced non-small-cell lung carcinoma. All patients had been previously treated with one chemotherapy regimen prior to this treatment.

Treatment: Treatment consisted of two chemotherapy drugs, topotecan (hycamtin) and gemcitabine (gemzar).

Toxicity: Grade 1-4 toxicities included neutropenia and thrombocytopenia. Other toxicities (grade 1-3) included anemia, fatigue, fever, headache, shortness of breath, nausea/emesis, anorexia, mucositis, dermatitis, arthralgia, and diarrhea.

Results: The overall median survival was 7 months.

Support: This study was supported by a grant from GlaxoSmithKline. GlaxoSmithKline markets topotecan.

Correspondence: David A. Rinaldi, MD

E-mail to a Friend Email Physician More Information